|
|
Volumn 27, Issue SUPPL. 1, 2006, Pages
|
|
Clinical study of the French cohort of Gaucher disease patients
a
|
|
Author keywords
Cohort study; Committee to Evaluate the Treatment of Gaucher disease (CETG)
|
|
Indexed keywords
ALGLUCERASE;
BIOCHEMICAL MARKER;
CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR;
IMIGLUCERASE;
MIGLUSTAT;
RECOMBINANT ENZYME;
1 DEOXYNOJIRIMYCIN;
BIOLOGICAL MARKER;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
GLUCOSYLCERAMIDASE;
RECOMBINANT PROTEIN;
ABDOMINAL PAIN;
ADULT;
ARTICLE;
ASTHENIA;
BONE INJURY;
BONE PAIN;
CONSENSUS DEVELOPMENT;
CONTROLLED STUDY;
DATA ANALYSIS;
DISEASE SEVERITY;
ENZYME THERAPY;
FRANCE;
GAUCHER DISEASE;
HUMAN;
MAJOR CLINICAL STUDY;
MEDICAL RECORD;
NEUROLOGIC DISEASE;
SCORING SYSTEM;
SPLENOMEGALY;
ADOLESCENT;
AGED;
CHILD;
CLASSIFICATION;
CLINICAL TRIAL;
COHORT ANALYSIS;
COMPARATIVE STUDY;
FOLLOW UP;
FORECASTING;
INFANT;
MIDDLE AGED;
NEWBORN;
PRESCHOOL CHILD;
SPLENECTOMY;
TIME;
TREATMENT OUTCOME;
1-DEOXYNOJIRIMYCIN;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ASTHENIA;
BIOLOGICAL MARKERS;
CHILD;
CHILD, PRESCHOOL;
COHORT STUDIES;
ENZYME INHIBITORS;
FOLLOW-UP STUDIES;
FORECASTING;
FRANCE;
GAUCHER DISEASE;
GLUCOSYLCERAMIDASE;
HUMANS;
INFANT;
INFANT, NEWBORN;
MIDDLE AGED;
RECOMBINANT PROTEINS;
SPLENECTOMY;
SPLENOMEGALY;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 33646085508
PISSN: 02488663
EISSN: 17683122
Source Type: Journal
DOI: 10.1016/S0248-8663(06)80006-8 Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
